Last reviewed · How we verify
Deferiprone oral solution
Deferiprone oral solution is a Small molecule drug developed by ApoPharma. It is currently FDA-approved. Also known as: DFP, Deferiprone extended release tablet formulation, Ferriprox, L1.
At a glance
| Generic name | Deferiprone oral solution |
|---|---|
| Also known as | DFP, Deferiprone extended release tablet formulation, Ferriprox, L1 |
| Sponsor | ApoPharma |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children (PHASE4)
- Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias (PHASE4)
- Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA) (PHASE2)
- Compassionate Use of Deferiprone in Patients With PKAN
- Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias (PHASE4)
- Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients (PHASE3)
- Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration (PHASE3)
- Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Deferiprone oral solution CI brief — competitive landscape report
- Deferiprone oral solution updates RSS · CI watch RSS
- ApoPharma portfolio CI
Frequently asked questions about Deferiprone oral solution
What is Deferiprone oral solution?
Deferiprone oral solution is a Small molecule drug developed by ApoPharma.
Who makes Deferiprone oral solution?
Deferiprone oral solution is developed and marketed by ApoPharma (see full ApoPharma pipeline at /company/apopharma).
Is Deferiprone oral solution also known as anything else?
Deferiprone oral solution is also known as DFP, Deferiprone extended release tablet formulation, Ferriprox, L1.
What development phase is Deferiprone oral solution in?
Deferiprone oral solution is FDA-approved (marketed).
Related
- Manufacturer: ApoPharma — full pipeline
- Also known as: DFP, Deferiprone extended release tablet formulation, Ferriprox, L1
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing